In Depth 4 Apr 2024 Seven diseases CRISPR technology could cure Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool. April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 3 Apr 2024 Hepatitis B: are we edging closer to a cure? Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease. April 3, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 27 Mar 2024 Are new treatments for multiple sclerosis on the horizon? As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise. March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Mar 2024 Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better? Discover how Novo Nordisk’s new experimental obesity pill, amycretin, could be even more efficient for weight loss than Wegovy. March 25, 2024 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Mar 2024 Biotech in France: What’s holding back progress and how to move forward? Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector. March 21, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 20 Mar 2024 Are molecular glues the key to undruggable targets? As more biopharmas get sticky with molecular glue developers and venture capital interest grows, here is a review of the field. March 20, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Mar 2024 Will the US biotech funding surge trigger a renaissance in the global biotech industry? After a couple of challenging years in biotech investment, the US leads the march for recovery. Delve into the specifics driving this uptick. March 18, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 14 Mar 2024 Rett syndrome: advances in gene therapy brings hope Explore the latest advancements in treating Rett syndrome, a rare genetic disorder, including groundbreaking gene therapies and drug trials. March 14, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Mar 2024 From LSD to healing minds: Where are we standing in psychedelic drug development? Delve into the growing sector of psychedelic drug development to find out where we are coming from, and where we are standing in the field. March 13, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2024 Biotech bankruptcies: what to expect in 2024 following a record year? 2023 broke the record for the highest number of biotech bankruptcies in a decade. Can biotechs mitigate the risk in 2024? March 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company. March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 6 Mar 2024 The biggest private biotech investments in February 2024 The companies BioAge Labs, Latigo Biotherapeutics, and Neurona Therapeutics bagged the biggest private biotech investments in February 2024. March 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email